Patents for A61K 49 - Preparations for testing in vivo (35,376) |
---|
04/17/2013 | CN102688506B Gastrointestinal contrast agent containing Chinese herbal extracts |
04/17/2013 | CN102600486B Medical ultrasonic coupling agent and preparation method thereof |
04/17/2013 | CN101948694B Rare earth upconversion nano crystal/silver difunctional composite nano material, preparation method thereof and application thereof in cancer detection and treatment |
04/17/2013 | CN101374555B Methods for measuring the metabolism of neurally derived biomolecules in vivo |
04/16/2013 | US8422755 System and method for synchronizing image sequences captured in-vivo for automatic comparison |
04/16/2013 | US8420603 SPARC and methods of use thereof |
04/16/2013 | US8420056 Abuse-proofed dosage form |
04/16/2013 | US8420055 Amine functionalized superparamagnetic nanoparticles for the synthesis of bioconjugates and uses therefor |
04/16/2013 | US8420054 Noninvasive method for measuring histamine from skin as an objective measurement of itch |
04/16/2013 | US8420053 Gastrin releasing peptide compounds |
04/16/2013 | US8420051 Muteins of hNGAL and related proteins with affinity for a given target |
04/11/2013 | WO2013051732A1 Liposome composite body |
04/11/2013 | WO2013021300A3 Imaging using sets of carbon nanotubes |
04/11/2013 | WO2013019151A3 Oxide ferrimagnetics with spinel structure nanoparticles and iron oxide nanoparticles, biocompatible aqueous colloidal systems comprising nanoparticles, ferriliposomes, and uses thereof |
04/11/2013 | WO2013010176A3 Pharmacophores for amyloid fibers involved in alzheimer's disease |
04/11/2013 | US20130091591 Artery- and vein-specific proteins and uses therefor |
04/11/2013 | US20130089505 Single vial formulation for medical grade cyanoacrylate |
04/11/2013 | US20130089495 Method for screening size of carrier |
04/11/2013 | DE102011054396A1 Use of substituted 3,3-dimethyl-2,3-dihydro-1H-indole derivatives as a marker and/or a contrast agent in an imaging process and/or in biomedical analysis |
04/11/2013 | CA2841867A1 Dye conjugated peptides for fluorescent imaging |
04/10/2013 | EP2579027A1 Fluorescent probe for imaging lymph nodes |
04/10/2013 | EP2578684A1 Antagonists of ligands and uses thereof |
04/10/2013 | EP2578237A1 Compositions and methods for enhancing contrast in imaging |
04/10/2013 | EP2576699A1 Naphthocyanines for use as contrast agents |
04/10/2013 | EP2575896A2 Magnetically responsive membrane structures |
04/10/2013 | EP2575772A2 Magnetic nanoparticles |
04/10/2013 | CN103038629A Fluorescent probe for imaging lymph nodes |
04/10/2013 | CN103038289A Naphthocyanines for use as contrast agents |
04/10/2013 | CN103030689A CART polypeptide compound, and preparation method and application of compound |
04/10/2013 | CN103027897A Method for preparing monodispersity hydrophobic drug nanoparticles by template method |
04/10/2013 | CN102552939B Targeting PLGA (poly(lactic-co-glycolic acid)) fluorescence probe coated with methylene blue and the preparation method thereof |
04/10/2013 | CN102397565B Target-dextran-USPIO (Ultra-small Superparamagnetic Iron Oxide) compound particle and preparation method and application thereof |
04/09/2013 | US8415304 Sparc and methods of use thereof |
04/09/2013 | US8414892 Uses of monoclonal antibody 8H9 |
04/09/2013 | US8414865 Use of Mycobacterium bovis BCG killed by extended freeze drying (EFD) for preventing or treating atherosclerosis |
04/09/2013 | US8414864 Gastrin releasing peptide compounds |
04/09/2013 | CA2677041C Multimeric conjugate |
04/09/2013 | CA2224176C Gene transfer for treating a connective tissue of a mammalian host |
04/04/2013 | WO2013049405A1 Remote assembly of targeted nanoparticles using complementary oligonucleotide linkers |
04/04/2013 | WO2013049112A1 Detection of biomarkers using magnetic resonance |
04/04/2013 | WO2013048022A2 Α-type zinc- phthalocyanine nanowires having enhanced water solubility and water dispersibility, composite of an α-type zinc- phthalocyanine nanowire/phenothiazine, and method for preparing same |
04/04/2013 | WO2013046076A1 Automated ultrasound mediated delivery. |
04/04/2013 | WO2013045662A1 Peptide margin imaging agents |
04/04/2013 | WO2013045650A2 Infusion imaging method |
04/04/2013 | WO2013045504A1 Perfluorinated nanoemulsions, method for preparing same, and use thereof as a contrast agent |
04/04/2013 | WO2013045333A1 Nanoemulsions and use thereof as contrast agents |
04/04/2013 | WO2013013067A3 Microbubble compositions, method of making same, and method using same |
04/04/2013 | WO2012177039A3 Mri contrast agent for lymphography based on iron oxide nanoparticles and method for imaging lymph node using the same |
04/04/2013 | US20130085384 Medical-surgical devices |
04/04/2013 | US20130084248 Stabilized, biocompatible gold nanoparticles |
04/04/2013 | US20130084247 Compositions and methods to prevent cancer with cupredoxins |
04/04/2013 | US20130084246 Method and system for quantitative renal assessment |
04/04/2013 | DE102009060317B4 Kontrastmittel zur Verwendung in einem bildgebenden Verfahren zur Diagnose einer metastasierenden Tumorerkrankung und Verfahren zur Abbildung eines metastasierenden Tumorgewebes Contrast agents for use in an imaging method of diagnosing a metastatic tumor and method for imaging a metastatic tumor tissue |
04/04/2013 | CA2850198A1 Remote assembly of targeted nanoparticles using complementary oligonucleotide linkers |
04/03/2013 | EP2574671A1 Antagonists of ligands and uses thereof |
04/03/2013 | CN103025758A IL-1 binding proteins |
04/03/2013 | CN103025357A Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types |
04/03/2013 | CN103025317A Nalbuphine-based formulations and uses thereof |
04/03/2013 | CN103025314A Magnetic nanoparticles |
04/03/2013 | CN103012562A Dual-targeting D-configuration polypeptides and drug delivery system thereof |
04/03/2013 | CN103012561A Small peptide for tumor targeted diagnosis |
04/03/2013 | CN103012401A Preparation method and application of anthraquinone polypyridine ligand and ruthenium-anthraquinone complex |
04/03/2013 | CN103007305A Preparation method of transparent bactericidal medical ultrasonic coupling agent |
04/03/2013 | CN103007304A CT/MRI (computerized tomography/magnatic resonance imaging) double-function Mn3O4 nanoparticles and preparation method thereof |
04/03/2013 | CN103007303A Core-shell type tri-modal nano contrast agent as well as preparation method and application thereof |
04/03/2013 | CN103007302A Gd2O3-TiO2 composite nanoparticle as well as preparation method and application thereof |
04/03/2013 | CN103007301A Ferroferric oxide nano particles with CT/MRI (Computed Tomography/Magnetic Resonance Imaging) double functions as well as preparation method and application thereof |
04/03/2013 | CN103007300A Macromolecule developing agent with passive-initiative dual tumor targeted function and synthesis thereof |
04/03/2013 | CN103007299A Parkinson's disease animal model platform and application of platform in medicine screening |
04/03/2013 | CN103007298A Medical lubricant for sterilizing and balancing potential of hydrogen and preparation process of medical lubricant |
04/03/2013 | CN103007297A Preparation method of lubricating agent for gastroscope |
04/03/2013 | CN103007296A Mould for intervention of liraglutide in GK rat and application thereof in intervention treatment diabetes B medicine |
04/03/2013 | CN103007295A Medical imaging material, and preparation method and application thereof |
04/03/2013 | CN103007285A Preparation method for folic acid-decorated and rare earth-modified carbon nano tube |
04/03/2013 | CN103006538A Ultrasonic microbubbles for treating arthritis and use thereof |
04/03/2013 | CN102389399B Preparation method of drug-loaded microspheres capable of enhancing anticancer effect of paclitaxel by ultraviolet radiation and application thereof |
04/03/2013 | CN101076356B Electroporation of mycobacterium and overexpression of antigens in mycobacteria |
04/03/2013 | CN101027099B Diagnostic marker for cancer |
04/02/2013 | US8410251 Antibody against calcified globule and use of the same |
04/02/2013 | US8410172 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
03/28/2013 | WO2013043902A1 Targeted nanoparticles joined to reporter molecules through multiple mechanisms |
03/28/2013 | WO2013041810A1 Stable, low-toxicity, sterilizable composition for ophthalmic dying |
03/28/2013 | WO2013041623A1 Novel manganese comprising nanostructures |
03/28/2013 | WO2013041250A1 Cross-linked poly-e-lysine non-particulate support |
03/28/2013 | WO2012123916A3 Activatable fluorogenic compounds and uses thereof as near infrared probes |
03/28/2013 | WO2012041292A3 Compounds for diagnosing neurodegenerative diseases at the retina |
03/28/2013 | US20130079767 Embolization |
03/28/2013 | US20130078189 Formation and uses of europium complexes |
03/28/2013 | US20130078188 Activatable cell penetrating peptides with quenched fluorophores |
03/28/2013 | US20130078187 Method for Selecting Bacteria with Anti-Oxidant Action |
03/28/2013 | CA2847804A1 Novel manganese comprising nanostructures |
03/28/2013 | CA2833589A1 Cross-linked poly-e-lysine non-particulate support |
03/27/2013 | EP2572736A1 Nanostructures comprising manganese |
03/27/2013 | EP2572735A1 Imaging diagnostics by combining contrast agents |
03/27/2013 | EP2571532A2 Il-1 binding proteins |
03/27/2013 | EP2571531A2 Stabilized fibronectin domain compositions, methods and uses |
03/27/2013 | EP2571529A2 Functional, cross-linked nanostructures for tandem optical imaging and therapy |
03/27/2013 | CN103002924A Compositions, methods and systems for the synthesis and use of imaging agents |
03/27/2013 | CN103002923A Stabilized fibronectin domain compositions, methods and uses |
03/27/2013 | CN103002921A Functional, cross-linked nanostructures for tandem optical imaging and therapy |